Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Desmoid Tumors × Bleomycin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 28 Lymphoma 15 Lymphoma, Large B-Cell, Diffuse 5 Vulvar Neoplasms 3 Neoplasms, Germ Cell and Embryonal 3 Lymphoma, Follicular 3 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Immunoblastic 2 Dendritic Cell Sarcoma, Interdigitating 2 Warts 1 Ulcer 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Skin Neoplasms 1 Seminoma 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Processes 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Neoplastic Processes 1 Neoplasms, Second Primary 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Intracranial Non-germinomatous Germ Cell Tumor 1 Hemangioma, Capillary 1 Hemangioma 1

Interventions

Imatinib Mesylate 3 Cryosurgery 3 nirogacestat 2 Blood Specimen Collection 2 strattice 1 liposomal doxorubicin 1 Toremifene 1 Taxes 1 Surveys and Questionnaires 1 Sunitinib 1 Saline Solution 1 Radiofrequency Ablation 1 Pregnancy 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Hydroxyurea 1 High-Intensity Focused Ultrasound Ablation 1 Electrochemotherapy 1 Doxorubicin 1 Data Collection 1 Cyclophosphamide 1 Cryotherapy 1 Bleomycin 1 Biopsy 1 Albumin-Bound Paclitaxel 1 Abdominoplasty 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06660121 2025-12-23

ECT-DESMO

Istituto Ortopedico Rizzoli

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡